Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic

Blood

Volumn 101, Issue 1, 2003, Pages 226-235

  Zhang, Dong ^a,b   Shankar, Premlata ^a,b   Xu, Zhan ^a,b   Harnisch, Brooke ^a,b   Chen, Gang ^a,b   Lange, Christoph ^a,b   Lee, Sandra J ^a,b   Valdez, Hernan ^a,b   Lederman, Michael M ^a,b   Lieberman, Judy ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD27 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GRANZYME A; HLA A2 ANTIGEN; HLA B8 ANTIGEN; PERFORIN;

ANTIGEN PRESENTATION; ARTICLE; CONTROLLED STUDY; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; EPSTEIN BARR VIRUS; EXOCYTOSIS; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIMIAN IMMUNODEFICIENCY VIRUS; T LYMPHOCYTE; VIRUS INFECTION;

EID: 0037221406     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0791     Document Type: Article

References (54)

1. + lymphocytes can control HIV infection in vitro by suppressing virus replication. Science. 1986;234:1563-1566.
2. Walker BD, Chakrabarti S, Moss B, et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature. 1987;328:345-348.
3. + T cells. Science. 1995;270:1811-1815.
4. Koup RA, Safrit JT, Cao Y, et al. Temporal association of cellular immune responses with the initial control of viremia in primary human immuno-deficiency virus type 1 syndrome. J Virol. 1994;68:4650-4655.
5. Borrow P, Lewicki H, Wei X, et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat Med. 1997;3:205-211.
6. + lymphocytes. Science. 1999;283:857-860.
7. Jin X, Bauer DE, Tuttleton SE, et al. Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected ma3caques. J Exp Med. 1999;189:991-998.
8. Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? a review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood. 2001;98:1667-1677.
9. Shankar, P, Xu Z, Lieberman J. Viral-specific cytotoxic T lymphocytes lyse HIV-infected primary T lymphocytes by the granule exocytosis pathway. Blood. 1999;94:3084-3093.
10. Andersson J, Behbahani H, Lieberman J, et al. Perforin is not co-expressed with granzyme A within cytotoxic granules in CD8 T lymphocytes present in lymphoid tissue during chronic HIV infection. AIDS. 1999;13:1295-1303.
11. - T lympho cyte granules in lymphoid tissue during acute human immunodeficiency virus type 1 infection. J Infect Dis. 2002;185:1355-1358.
12. Chen G, Shankar P, Lange C, et al. CD8 T cells specific for human immunodeficiency virus, Epstein-Barr virus, and cytomegalovirus lack molecules for homing to lymphoid sites of infection. Blood. 2001;98:156-164.
13. Appay V, Nixon DF, Donahoe SM, et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J Exp Med. 2000;192:63-75.
14. - T cells. J Exp Med. 1997;186:1407-1418.
15. - T lymphocytes. J Immunol. 2001;167:181-187.
16. - T cell memory: Relationships between epitope specificity, cell phenotype, and immediate effector function. J Immunol. 2001;167:2019-2029.
17. - T cells vary in differentiation phenotype in different persistent virus infections. Nat Med. 2002;8:379-385.
18. Lieberman J, Manjunath N, Shankar P. Avoiding the kiss of death: How HIV and other chronic viruses survive. Curr Opin Immunol 2002;14:478-486.
19. Shankar P, Russo M, Harnisch B, et al. Impaired function of circulating HIV-specific CD8(+) T cells in chronic human immunodeficiency virus infection. Blood. 2000;96:3094-3101.
20. Trimble LA, Lieberman J. Circulating CD8 T lymphocytes in human immunodeficiency virus-infected individuals have impaired function and downmodulate CD3 zeta, the signaling chain of the T-cell receptor complex. Blood. 1998;91:585-594.
21. Ostrowski MA, Justement SJ, Ehler L, et al. The role of CD4(+) T cell help and CD40 ligand in the in vitro expansion of HIV-1-specific memory cytotoxic CD8(+) T cell responses. J Immunol. 2000;165:6133-6141.
22. Altman JD, Moss PAH, Goulder PJR, et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 1996;274:94-96.
23. Johnson RP, Trocha A, Yang L, et al. HIV-1 gag-specific cytotoxic T lymphocytes recognize multiple highly conserved epitopes: Fine specificity of the gag-specific response defined by using unstimulated peripheral blood mononuclear cells and cloned effector cells. J Immunol. 1991;147:1512-1521.
24. Ogg GS, Jin X, Bonhoeffer S, et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science. 1998;279:2103-2106.
25. Walker BD, Flexner C, Paradis TJ, et al. HIV-1 reverse transcriptase is a target for cytotoxic T lymphocytes in infected individuals. Science. 1988;240:64-66.
26. + T cells by a cytotoxic T-lymphocyte clone directed against a novel A2-restricted reverse-transcriptase epitope. J Acquir Immune Defic Syndr Hum Retrovirol. 1998;19:111-120.
27. Shankar P, Fabry JA, Fong DM, Lieberman J. Three regions of HIV-1 gp160 contain clusters of immunodominant CTL epitopes. Immunol Lett. 1996;52:23-30.
28. Wills MR, Carmichael AJ, Mynard K, et al. The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: Frequency, specificity, and T-cell receptor usage of pp65-specific CTL. J Virol. 1996;70:7569-7579.
29. + T lymphocytes using MHC tetramers in kidney transplant patients and healthy participants. Transplantation. 2000;69:2243-2250.
30. + cytotoxic T-lymphocytes in liver transplant patients. Transplantation. 2000;69:2251-2259.
31. Steven NM, Annels NE, Kumar A, et al. Immediate early and early lytic cycle proteins are frequent targets of the Epstein-Barr virus-induced cytotoxic T cell response. J Exp Med. 1997;185:1605-1617.
32. + T cells during the primary immune response to Epstein-Barr virus in vivo. J Exp Med. 1998;187:1395-1402.
33. Lieberman J, Fabry JA, Shankar P, Beckett L, Skolnik PR. Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-sero-positive subjects. AIDS Res Hum Retroviruses. 1995;11:257-271.
34. Champagne P, Ogg GS, King AS, et al. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature. 2001;410:106-111.
35. + T cells during the chronic phase of infection. J Virol. 2001;75:2458-2461.
36. + T cells to cause immunopathology. J Exp Med. 1998;187:763-774.
37. Oxenius A, Bachmann MF, Zinkernagel RM, Hengartner H. Virus-specific MHC-class II-restricted TCR-transgenic mice: Effects on humoral and cellular immune responses after viral infection. Eur J Immunol. 1998;28:390-400.
38. Liu H, Andreansky S, Diaz G, Hogg T, Doherty PC. Reduced functional capacity of CD8(+) T cells expanded by post-exposure vaccination of gamma-herpesvirus-infected CD4-deficient mice. J Immunol. 2002;168:3477-3483.
39. + CD8 T lymphocytes correlates with reduced viral plasma RNA after primary HIV infection. AIDS. 1999;13:891-899.
40. + T cells. Nature. 1999;401:76-79.
41. Nagler-Anderson C, Lichtenheld M, Eisen HN, Podack ER. Perforin mRNA in primary peritoneal exudate cytotoxic T lymphocytes. J Immunol. 1989;143:3440-3443.
42. Stefanova I, Saville MW, Peters C, et al. HIV infection-induced posttranslational modification of T cell signaling molecules associated with disease progression. J Clin Invest. 1996;98:1290-1297.
43. Sieg SF, Bazdar DA, Harding CV, Lederman MM. Differential expression of interleukin-2 and gamma interferon in human immunodeficiency virus disease. J Virol. 2001;75:9983-9985.
44. Zhang J, Scordi I, Smyth MJ, Lichtenheld MG. Interleukin 2 receptor signaling regulates the perforin gene through signal transducer and activator of transcription (Stat)5 activation of two enhancers. J Exp Med. 1999;190:1297-1308.
45. Trimble LA, Kam LW, Friedman RS, Xu Z, Lieberman J. CD3zeta and CD28 down-modulation on CD8 T cells during viral infection. Blood. 2000;96:1021-1029.
46. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T-cell activation. J Virol. 2000;74:7320-7330.
47. + T cell responses associated with control of viremia. Science. 1997;278:1447-1450.
48. Zajac AJ, Blattman JN, Murali-Krishna K, et al. Viral immune evasion due to persistence of activated T cells without effector function. J Exp Med. 1998;188:2205-2213.
49. Kalams SA, Walker BD. The critical need for CD4 help in maintaining effective cytotoxic T lymphocyte responses. J Exp Med. 1998;188:2199-2204.
50. Kalams SA, Buchbinder SP, Rosenberg ES, et al. Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection. J Virol. 1999;73:6715-6720.
51. Yao QY, Tierney RJ, Croom-Carter D, et al. Frequency of multiple Epstein-Barr virus infections in T-cell-immunocompromised individuals. J Virol. 1996;70:4884-4894.
52. Gerna G, Percivalle E, Baldanti F, et al. Diagnostic significance and clinical impact of quantitative assays for diagnosis of human cytomegalovirus infection/disease in immunocompromised patients. New Microbiol. 1998;21:293-308.
53. Phillips RE, Rowland-Jones S, Nixon DF, et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature. 1991;354:453-459.
54. Collins KL, Chen BK, Kalams SA, Walker BD, Baltimore D. HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature. 1998;391:397-401.